H1B Salary Data

Home › Employers › BioMed Laboratories, LLC

BioMed Laboratories, LLC: H-1B salaries and sponsorship

BioMed Laboratories, LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $92,700.

Applications (LCAs)3
Certified3
Employer addressAlpharetta, GA
H-1B dependent employerNo
Median offered salary$92,700
Middle half of salaries$86,350–$105,276
10th–90th percentile$82,540–$112,822

Does BioMed Laboratories, LLC sponsor H-1B visas?

BioMed Laboratories, LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 13, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Quality Assurance Engineer III1$117,853
Master Scheduler and Supply Chain Analyst1$92,700
QC Laboratory Chemist1$80,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20241$117,853
FY20252$86,350

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Master Scheduler and Supply Chain Analyst$92,700
Level I
Dallas, TXMay 13, 2025Oct 1, 2025Certified
QC Laboratory Chemist$80,000
Level I
Dallas, TXMay 9, 2025Oct 1, 2025Certified
Quality Assurance Engineer III$117,853–$120,000
Level IV
Dallas, TXFeb 20, 2024Mar 25, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).